Zobrazeno 1 - 10
of 18
pro vyhledávání: '"M. V. Berkut"'
Autor:
D. S. Plevako, M. S. Knyazeva, E. I. Sidina, M. V. Berkut, S. A. Reva, S. S. Tolmachev, A. S. Artemyeva, A. K. Nosov, A. V. Malek
Publikováno v:
Vestnik Urologii, Vol 10, Iss 4, Pp 98-108 (2023)
Introduction. A combination of antiandrogen and cytostatic drugs was justified in the neoadjuvant therapy of patients with high-risk prostate cancer (HiRPCa) in some clinical trials. The effectiveness of such therapy in each individual case depends o
Externí odkaz:
https://doaj.org/article/6fef6f155e154d7dbe7e8f8f0f30be65
Publikováno v:
Vestnik Urologii, Vol 10, Iss 3, Pp 44-53 (2022)
Introduction. To date, the impact of the time interval from diagnostic prostate biopsy to radical prostatectomy on treatment outcomes remains a topical issue.Objective. To evaluate the effect of the timespan from diagnosis to radical treatment of pro
Externí odkaz:
https://doaj.org/article/530cfc06e10c47069d581c2293d78340
Autor:
A. K. Nosov, M. V. Berkut, E. M. Mamizhev, T. Yu. Galunova, D. I. Rumyantseva, D. P. Semeyko, S. A. Reva, S. Yu. Konyashkina
Publikováno v:
Creative surgery and oncology. 13:13-20
Introduction. The key treatment for high-risk non-invasive bladder tumor or invasive urothelial cancer remains radical cystectomy (RCE), which provides the best survival rates. At the same time, the incidence of infectious complications in a number o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc6fa52d5230318a0a67b5f4c7b9b572
https://doi.org/10.24060/2076-3093-2023-2
https://doi.org/10.24060/2076-3093-2023-2
Autor:
E. V. Mamizhev, M. V. Berkut, D. I. Rumyantseva, N. A. Shchekuteev, N. F. Krotov, A. M. Sigaev, N. I. Podvigina, D. V. Nekrasov, A. K. Nosov
Publikováno v:
Cancer Urology. 18:81-92
Background. Surgical treatment after chemotherapy is extremely difficult technically and should only be performed in a specialized medical center. The postoperative period after these surgical interventions is aimed not only at minimizing complicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33d6af8d9c909b4e89da8e294f7fdcb3
https://doi.org/10.17650/1726-9776-2022-18-4-81-92
https://doi.org/10.17650/1726-9776-2022-18-4-81-92
Autor:
D. S. Plevako, M. S. Knyazeva, E. I. Sidina, M. V. Berkut, S. A. Reva, S. S. Tolmachev, A. S. Artemyeva, A. K. Nosov, A. V. Malek
Publikováno v:
Urology Herald. 10:98-108
Introduction. A combination of antiandrogen and cytostatic drugs was justified in the neoadjuvant therapy of patients with high-risk prostate cancer (HiRPCa) in some clinical trials. The effectiveness of such therapy in each individual case depends o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37e88890f48701e71870d6caa9a27b5d
https://doi.org/10.21886/2308-6424-2022-10-4-98-108
https://doi.org/10.21886/2308-6424-2022-10-4-98-108
Autor:
A. K. Nosov, E. M. Mamizhev, N. A. Shchekuteev, D. P. Semeyko, P. A. Lushina, D. I. Rumyantseva, M. V. Berkut
Publikováno v:
Cancer Urology. 18:27-34
Background. The kidney cancer treatment remains cornerstone problem in our country for healthcare. Survival results of partial nephrectomy as a radical nephrectomy are similar in groups of patients with the same morphological features and was confirm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b92f43ac96ac5c072acf565d6b4dbde1
https://doi.org/10.17650/1726-9776-2022-18-3-27-34
https://doi.org/10.17650/1726-9776-2022-18-3-27-34
Autor:
A. K. Nosov, E. M. Mamizhev, B. I. Aslanov, R. I. Ryabinin, Kh. N. Bayramov, D. I. Rumyantseva, M. V. Berkut, D. V. Nekrasov
Publikováno v:
Cancer Urology. 18:26-37
Objective. Radical nephrectomy with thrombectomy of the inferior vena cava is the preferred treatment for renal cell carcinoma with an tumor thrombosis. We describe our experience and presentreview of the literature evaluating the feasibility and saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f8c41967ab0a34ef481b9e118f87cd2
https://doi.org/10.17650/1726-9776-2022-18-1-26-37
https://doi.org/10.17650/1726-9776-2022-18-1-26-37
Autor:
A. K. Nosov, D. I. Rumyantseva, E. M. Mamizhev, P. A. Lushina, N. A. Shchekuteev, M. V. Berkut
Publikováno v:
Cancer Urology. 18:127-135
The ureter is a unique tubular structure, extremely sensitive to exogenous influences and directly affects to renal function. The injuries of the ureter remain one of the most difficult problems requiring an extraordinary surgical approach in urology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efb298dbfe627e1efb8521e04a25d057
https://doi.org/10.17650/1726-9776-2022-18-1-127-135
https://doi.org/10.17650/1726-9776-2022-18-1-127-135
Autor:
S. A. Reva, A. K. Nosov, V. D. Korol, A. V. Arnautov, I. V. Zyatchin, M. V. Berkut, S. B. Petrov, A. M. Belyaev
Publikováno v:
Onkourologiâ, Vol 17, Iss 2, Pp 54-61 (2021)
Background. High-risk prostate cancer (PCa) occurs in 15-25 % of newly diagnosed cases and is a life-threatening condition that requires active treatment. In recent years, the percentage of high-risk PCa has significantly increased, as well as the nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d263d549497f3384a7e35833962f6135
https://oncourology.abvpress.ru/oncur/article/view/1378
https://oncourology.abvpress.ru/oncur/article/view/1378
Publikováno v:
Onkourologiâ, Vol 17, Iss 1, Pp 167-177 (2021)
The emergence and continuous development of immune checkpoint inhibitors (ICIs) therapy brings a revolution in cancer therapy history including urothelial carcinoma. Early accurate targeting and adequate treatment are critical to patient prognosis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b796191c3df2c7d610ca4e6fb86dd07f
https://doi.org/10.17650/1726-9776-2021-17-1-167-177
https://doi.org/10.17650/1726-9776-2021-17-1-167-177